NYU Langone Health

Research CenterTreats Aortic, Mitral, and Tricuspid valves

AI Description

NYU Langone’s Heart Valve Center provides evaluation and treatment for aortic, mitral, and tricuspid valve disease through cardiologists, interventional cardiologists, and cardiac surgeons. Care includes TAVR, MitraClip and other transcatheter procedures, robotic and minimally invasive mitral valve repair, and open valve repair or replacement surgery.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

550 First Avenue
New York, NY 10016

Clinical Trials

Active, not recruiting

CLASP IID/IIF

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Public sites
60
Start date
Nov 30, 2018
Active, not recruiting

SURTAVI

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Public sites
56
Start date
Apr 1, 2012
Active, not recruiting

P3

PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Public sites
62
Start date
Mar 1, 2016
Recruiting

PROGRESS

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Public sites
57
Start date
Oct 12, 2021
Recruiting

RESTORE

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Public sites
65
Start date
Feb 6, 2025
Active, not recruiting

SMART

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

Public sites
59
Start date
Apr 2, 2021
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017

Nearby Centers